Liver Biopsy Analysis Has a Low Level of Performance for Diagnosis of Intermediate Stages of Fibrosis

Clinical Gastroenterology and Hepatology

Volumn 10, Issue 6, 2012, Pages

  Poynard, Thierry ^a   Lenaour, Gilles ^a   Vaillant, Jean Christophe ^a   Capron, Frederique ^a   Munteanu, Mona ^b   Eyraud, Daniel ^a   Ngo, Yen ^b   M'Kada, Helmi ^a   Ratziu, Vlad ^a   Hannoun, Laurent ^a   Charlotte, Frederic ^a  

^a ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^b Biopredictive   (France)

Author keywords

Biomarkers; FibroSure; FibroTest; Gray Zone; Obuchowski Measure

Indexed keywords

ARTICLE; CHRONIC LIVER DISEASE; CONTROLLED STUDY; DATA BASE; DIAGNOSTIC ACCURACY; DISEASE SEVERITY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER; LIVER BIOPSY; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; SCORING SYSTEM;

EID: 84861330568     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cgh.2012.01.023     Document Type: Article

References (23)

1. Nguyen D., Talwalkar J.A. Noninvasive assessment of liver fibrosis. Hepatology 2011, 53:2107-2110.
2. EASL Clinical Practice Guidelines: management of hepatitis C virus infection. J Hepatol 2011, 55:245-264. European Association for the Study of the Liver.
3. Poynard T. First-line assessment of patients with chronic liver disease with non-invasive techniques and without recourse to liver biopsy. J Hepatol 2011, 54:586-587.
4. Vergniol J., Foucher J., Terrebonne E., et al. Non-invasive tests for fibrosis and liver stiffness predict 5-year outcomes of patients with chronic hepatitis C. Gastroenterology 2011, 140:1970-1979.
5. Poynard T., Ngo Y., Munteanu M., et al. Noninvasive markers of hepatic fibrosis in chronic hepatitis B. Curr Hepatol Rep 2011, 10:87-97.
6. Naveau S., Gaudé G., Asnacios A., et al. Diagnostic and prognostic values of noninvasive biomarkers of fibrosis in patients with alcoholic liver disease. Hepatology 2009, 49:97-105.
7. Poynard T., Lassailly G., Diaz E., et al. Performance of biomarkers FibroTest, ActiTest, SteatoTest, and NashTest in patients with severe obesity: meta analysis of individual patient data. Plos One 2012, 7:e30325.
8. Castéra L., Foucher J., Bernard P.H., et al. Pitfalls of liver stiffness measurement: a 5-year prospective study of 13,369 examinations. Hepatology 2010, 51:828-835.
9. Poynard T., Munteanu M., Deckmyn O., et al. Applicability and precautions of use of liver injury biomarker FibroTest: a reappraisal at 7 years of age. BMC Gastroenterol 2011, 11:39.
10. Gebo K.A., Herlong H.F., Torbenson M.S., et al. Role of liver biopsy in management of chronic hepatitis C: a systematic review. Hepatology 2002, 36:S161-S172.
11. Bedossa P., Poynard T. An algorithm for the grading of activity in chronic hepatitis C: the METAVIR Cooperative Study Group. Hepatology 1996, 24:289-293.
12. Bedossa P., Dargère D., Paradis V. Sampling variability of liver fibrosis in chronic hepatitis C. Hepatology 2003, 38:1449-1457.
13. Rousselet M.C., Michalak S., Dupré F., et al. Sources of variability in histological scoring of chronic viral hepatitis. Hepatology 2005, 41:257-264.
14. Lambert J., Halfon P., Penaranda G., et al. How to measure the diagnostic accuracy of noninvasive liver fibrosis indices: the area under the ROC curve revisited. Clin Chem 2008, 54:1372-1378.
15. Guha I.N., Myers R.P., Patel K., et al. Biomarkers of liver fibrosis: what lies beneath the receiver operating characteristic curve?. Hepatology 2011, 54:1454-1462.
16. Poynard T., De Ledinghen V., Zarski J.P., et al. Relative performances of FibroTest, Fibroscan and biopsy for assessing the stage of liver fibrosis in patients with chronic hepatitis C: a step toward the truth in the absence of a gold standard. J Hepatol 2012, 56:541-548.
17. Poynard T., Mathurin P., Lai C.L., et al. A comparison of fibrosis progression in chronic liver diseases. J Hepatol 2003, 38:257-265.
18. Michalak S., Rousselet M.C., Bedossa P., et al. Respective roles of porto-septal fibrosis and centrilobular fibrosis in alcoholic liver disease. J Pathol 2003, 201:55-62.
19. DeLong E.R., DeLong D.M., Clarke-Pearson D.L. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 1988, 44:837-845.
20. Hintze J.L. NCSS 2007 user guide 2007, Number Cruncher Statistical Systems software, Kaysville, UT.
21. Sebastiani G., Gkouvatsos K., Plebani M. Non-invasive assessment of liver fibrosis: it is time for laboratory medicine. Clin Chem Lab Med 2011, 49:13-32.
22. Ghany M.G., Strader D.B., Thomas D.L., et al. Diagnosis, management, and treatment of hepatitis C: an update. Hepatology 2009, 49:1335-1374.
23. Poynard T., Ingiliz P., Elkrief L., et al. Concordance in a world without a gold standard: a new non-invasive methodology for improving accuracy of fibrosis markers. Plos One 2008, 3:e3857.